IRWD
Ironwood Pharmaceuticals, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss +15.3% · neue Nettopositionen 0.0% — Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q1 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 88 | -4 | 110.50M | $465.13M | +4 | −8 |
| Q1 2026 | 94 | +9 | 125.58M | $394.14M | +11 | −2 |
| Q4 2025 | 85 | +2 | 100.81M | $339.86M | +2 | — |
| Q3 2025 | 17 | 0 | 58.02M | $76.00M | — | — |
| Q2 2025 | 14 | 0 | 58.90M | $42.25M | +1 | −1 |
| Q1 2025 | 11 | 0 | 30.28M | $44.51M | +1 | −1 |
| Q4 2024 | 11 | 0 | 26.27M | $116.38M | +1 | −1 |
| Q3 2024 | 10 | -2 | 15.74M | $64.83M | — | −2 |
| Q2 2024 | 12 | — | 17.55M | $114.44M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 9.94M | +9.6% | $14.61M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | Millennium Management ✦ | 6.36M | +191.7% | $9.35M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passiv) | 3.50M | -58.0% | $5.14M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passiv) | 3.42M | +3.4% | $5.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passiv) | 3.42M | +3.4% | $5.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 2.52M | +535.8% | $3.71M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 2.52M | +535.8% | $3.71M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 2.52M | +535.8% | $3.71M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 2.52M | +535.8% | $3.71M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 2.52M | +535.8% | $3.71M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 1.53M | +33.1% | $2.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 1.23M | +42.1% | $1.80M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 940.55K | +67.8% | $1.38M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 940.55K | +67.8% | $1.38M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Marshall Wace ✦ | 557.52K | Neu | $819,557 | 0.0% | New | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 171.28K | +78.6% | $252,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 109.72K | +62.0% | $161,294 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 109.72K | +62.0% | $161,294 | 0.0% | ▲ Add | 4 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Marshall Wace | $819,557 | 0.0% |
Ausgestiegen
| Norges Bank | $1.12M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 222 Inhaber, 159.91M Anteile, $533.78M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.